Transthyretin Amyloidosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Transthyretin Amyloidosis stocks.

Transthyretin Amyloidosis Stocks Recent News

Transthyretin Amyloidosis

Transthyretin Amyloidosis (ATTR) is a rare, progressive, and fatal genetic disorder caused by the buildup of abnormal proteins in the body's organs and tissues. The abnormal proteins, called amyloid, are made up of a protein called transthyretin (TTR). As the amyloid builds up, it can damage organs and tissues, leading to a variety of symptoms. Symptoms of ATTR can include peripheral neuropathy, autonomic neuropathy, cardiomyopathy, and carpal tunnel syndrome. Treatment options for ATTR include medications, lifestyle changes, and organ transplantation.

Browse All Tags